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Introduction 
 
Recent public attitude research undertaken by the Project on Emerging Nanotechnologies 
indicated a desire on the part of the public for (A) more pre- and post-market testing/tracking 
of nanotechnology-based products and (B) a greater disclosure by firms producing these 
products of their possible environmental and human health impacts (Macoubrie, 2005).  What 
the public is asking is: “Are nanotechnologies safe?”    
 
In addressing this question, businesses concerned with the potential toxicology of nano-based 
products face two interrelated challenges regarding testing: speed and cost.  Given both 
domestic and global competition, firms are under pressure to develop and introduce new 
nanotechnology-based products into the marketplace rapidly or face potential losses in market 
share, revenues, and strategic position. This means that companies need toxicity screening 
methods that can fit into product development cycles, which will allow environmental and 
human health problems to be identified early and hopefully engineered out of products before 
they are introduced into the marketplace.  These screening techniques also have to be 
affordable.  Given the many small businesses and start-ups involved with nanotechnology, 
financial constraints will limit their options vis-à-vis toxicity testing.  Realizing this need, the 
Project on Emerging Nanotechnologies launched an initiative to work with firms and scientists to 
develop and apply fast-turnaround toxicity screening methods to emerging nanotech products. 
 
This proof-of-concept study involved the development and application of a genomic-based, 
ecotoxitity screening method to nano-scale iron particles being used for environmental 
remediation.  Ecotoxicity is an area that has received far less attention and funding than the 
study of the potential human health impacts of nanomaterials.   The screening was completed 
in less than four months with the complete cooperation of the company and the test showed no 
significant ecotoxicity effects for two important indicator species.  It is important to remember 
that the findings do not constitute a product endorsement but an additional set of data that the 
company and consumers can evaluate to make more informed decisions. 
 
David Rejeski 
Director, Project on Emerging Nanotechnologies 
Washington, DC 
December 2005 
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Executive Summary 
 
 
The increasingly rapid introduction of nano-based substances into the marketplace will require 
new methods to assess both short and long-term environmental impacts.  This project explores 
the application of genomics technologies to nanotechnology, to provide faster, cheaper, and 
more sophisticated ecotoxicity testing.  Microarrays – a relatively new technology capable of 
measuring subtle changes in DNA in response to exposure to toxins -- were used in conjunction 
with more traditional methods already approved by the EPA to assess ecotoxicity. 
 
The goal was to demonstrate the potential of this approach for ecotoxicity screening by 
collaborating directly with a company that had developed an engineered nanomaterial.  The 
company, Toda, manufactures Reactive Nano-Iron Particles (RNIP), which are currently being 
used to remediate toxic waste sites. 
 
The project combined both a standard EPA-approved ecotoxicology test using daphnia (a water 
flea) with assays using a newly developed, 2000-gene DNA array for the fathead minnow, an 
important indicator species that EPA uses for freshwater testing.  Three primary advantages 
emerged: 
 
 
• Speed: All testing was completed within 4 months.  This fast turnaround provides 
important advantages to businesses seeking to screen out potential environmental risks 
early in the product development cycle, before products enter the market.   
 
• Sensitivity:  The genetic based screens allow the examination of a variety of toxicity 
endpoints and sub-lethal effects that standard ecotoxicology testing often does often not 
address. 
 
• Cost:  This approach presently costs in the range of $20,000 – 40,000 and the costs can 
be expected to drop given the rapid cost decreases in DNA arrays. 
 
 
The testing of the Reative Nano-Iron Particles revealed no significant toxicity issues for the 
material, though the tests are not all-inclusive since only two species were studied, and only 
2000 genes are printed on the DNA array.  However, data of this type can serve to quickly 
highlight toxic materials and can serve as a basis for more detailed mechanistic studies.    
 
 
Importantly, the testing design described in this report can serve as a model for other 
companies that are currently developing nanotechnologies.  Having these types of rapid 
screening tests available allows for quick screening, data analysis, and data dissemination, 
which ultimately will build public trust and help ensure eco-safe nano-products. 
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I.  Background 
 
In August 2004, the Woodrow Wilson International Center for Scholars hosted a meeting in 
Washington, DC, to explore both the applications and implications of nanotechnology.   At that 
meeting questions were raised about the current state-of-the-science of the ecotoxicology of 
engineered nanoparticles.  Until that point, ‘eco-nano’ research had focused primarily on 
applications such as remediation and green manufacturing (see Appendix, Table 2), not on 
nanoparticles themselves as potential toxicants in the environment.  Although the US EPA 
initiated funding to study the possible environmental implications (versus applications) of 
nanotechnology in 2004  However, there is a lengthy process of writing grants, peer review, 
and approval of funding before research can begin.  It is evident that information on the impact 
of NP on the environment will lag years behind the commercialization and use of such particles 
for environmental applications.  
 
The Project on Emerging Nanotechnologies at the Wilson Center saw a need to fill this 
information gap and began an initiative to help validate new techniques for the rapid testing of 
nanoparticles to determine their effects on species that are good indicators of ecosystem 
health.  The ultimate goal is to establish simple, cost-effective methods that can be used to 
screen nano-based substances and products for eco-toxicity before they are commercialized 
and in the marketplace.  The establishment and validation of new techniques could also 
increase public trust in both government and industry and raise consumer confidence in 
emerging products. 
 
Existing techniques for testing compounds 
To measure the toxicity of a compound, short (acute) and longer (chronic) term exposures are 
run using one or more environmental "indicator species".    The standard ‘value’ that is used for 
comparing toxicity of chemicals is the 48-hour LC50, which is the amount of chemical needed to 
kill 50% of the animals in 48 hours (LC = Lethal Concentration).  Other parameters that are 
measured in these bioassays include measuring fertility, fecundity, and egg hatchability of 
animals and survival of young.  While these endpoints have high ecological value, they often 
lack information about the compound’s mechanism of action and are typically not sensitive 
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enough to measure low dose effects of a compound.  Finally, these biological endpoints are 
expensive to acquire.   
 
Use of microarray technology for testing nanoparticles 
Microarrays (also called gene chips) are tools that are made by spotting or synthesizing 
hundreds to thousands of genes specific to an organism onto a solid support matrix (Brown and 
Botstein, 1999; Brazma and Vilo, 2000; Burgess, 2001;  Churchill, 2002).  Microarrays detect 
changes in messenger RNA (mRNA) within an animal.   By measuring mRNA, one can detect 
subtle responses in an animal upon exposure to a compound.   Microarrays offer the advantage 
of being able to provide biologically relevant, mechanistically based data compared to existing 
assays that are currently used for compound screening.   Microarrays can also be used to detect 
adverse responses of animals to toxicants earlier than existing assays, which often measure 
various physiological endpoints.  This “early detection” is because changes in the normal 
physiology of an animal due to exposure to compounds in the environment are ultimately a 
result of initial changes at the molecular and cellular levels.   In addition, microarrays can be 
used to identify dose response relationships for compounds (Larkin et al., 2003) and therefore 
could be used to identify levels of exposure of animals in a laboratory or field setting. 
 
Animal models  
Fathead minnows (Pimephales promelas) were chosen as a model species in this study for 
several reasons.   First and most important, they have been used as a standard test species for 
aquatic toxicology since the 1960s (Mayer and Ellersieck 1986) and are widely used in eco-
toxicology.  There are over 9,000 records for fathead minnows in the ECOTOX database alone.   
Second, their reproductive physiology is well known (Jensen et al., 2001), and they can be 
propagated easily in the laboratory.  Third, there is a 2,000 gene microarray available for this 
species.  While there are larger, whole genome microarrays available in other aquatic species 
like zebrafish, for this project we wanted to use a sentinel species that is found in the United 
States and is commonly used as a standard species for eco-toxicology. 
 
Water fleas (Daphnia magna) were also used to examine the toxicity of RNIP.  Daphnia are 
small crustaceans that live in fresh water such as ponds and lakes. They are an important 
source of food for fish and other aquatic organisms. Like the fathead minnow, Daphnia are 
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commonly used as a bioindicator species by various governmental agencies, including the US 
EPA.  This species is also easily grown and maintained in a laboratory setting. 
 
Industry Partnership 
For the first phase of this project, we chose to work with a company that had already 
introduced a product into the market.  Several nanoparticle products are currently in use  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and commercially available.  These products had been approved for use by the US EPA and 
presented a baseline of ‘eco-nano-technologies’.  With input from US EPA, we requested the 
collaboration of one of the largest companies, Toda America, which is presently manufacturing 
Reactive Nano-Iron Particles (RNIP) for use in superfund site remediation (Appendix 1).  Toda 
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Figure 1:  Rapid gene expression screening using a fathead minnow microarray. 
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America donated 1 kg (250 g RNIP in 750 mL water, as a slurry) for toxicity testing using 
standard aquatic species.   
 
Compound used  
The reactive Nano Iron Particles (RNIP) that were used in this study are iron solids with an 
average particle size of 70 nanometers, composed of an iron oxide shell and an elemental iron 
core.  In comparison, a typical bacterial cell is approximately 1000 nanometers in diameter. One 
property that characterizes these particles from their micro-scale counterparts is a large reactive 
surface area of over 9,000 square feet per ounce (28.27 square meter per mL) of material. The 
ability of iron to rust, or oxidize, gives it the ability to treat hazardous substances and 
chemicals. The particles can be injected directly into groundwater or used to detoxify 
contaminated water in above-ground tanks.  The technology has been shown to be very 
effective in treating chlorinated organic solvents, organochlorine pesticides, and polychlorinated 
biphenyls (PCBs) (Zhang, 2003).  Though the use of iron for remediation has been generally 
accepted as an environmentally safe practice, applications so far have not made use of particles 
in the nanoscale range.  Two important questions raised are whether our understanding of iron 
at a bulk or micro scale translates to the nano-scale and whether the large increases in 
oxidative ability also poses additional threats to the environment.   
 
II. Overview of Project 
The goal of the project was to develop a quick turnaround genomic based ecotoxicity screen for 
companies developing and commercializing new nanotechnologies which provides results in 3-4 
months.  Based on these efforts, we hope to encourage industries that are developing 
nanotechnologies to test their materials using genomic tools. 
 
Study Design 
The project utilized both a standard EPA-approved ecotoxicology test using daphnia with assays 
using a newly developed, 2000-gene DNA microaarray for the fathead minnow, an important 
indicator species that EPA uses for freshwater testing   From the initial assays to the final 
report, the process took approximately 4 months (May-August 2005). 
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Step 1:  Range-finding assay using water fleas (Daphnia magna) 
Step 2:  Exposure studies using fathead minnows (Pimephales promelas) exposed to a high, but 
tolerable dose of RNIP for 5 days 
Step 3:  Gene expression study to examine changes in liver and gill of fish using DNA 
microarrays 
 
III.  Daphnia study 
Initial range find-studies were carried out with a common aquatic 
zooplankton, Daphnia magna, the water flea (picture at right).  Daphnia are 
the basis of many aquatic food chains since they filter-feed on phytoplankton 
(microscopic algae), and are in turn eaten by fish.  Daphnia are also used by 
the US EPA as a standard organism for testing the toxicity of various chemicals.  Therefore a 
large database is available to compare the toxicity of new chemicals to those that are already in 
use.   
The 48-hour LC50 of RNIP was found experimentally to be ~55 parts per million (ppm), which is 
approximately the same as that for bulk iron.  Figure 2 below shows mortality after exposures 
to various concentrations of RNIP. 
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Figure 2:  Daphnia mortality curve. 
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Based on a toxicity rating scale that is used by toxicologists to classify compounds for aquatic 
toxicity, RNIP would be considered slightly toxic (see Table 1).  In addition, 55 ppm of RNIP is 
an extremely high dose, and would likely not be seen in the watershed after remediation is 
completed. 
 
 
 
 
 
 
 
 
 
TABLE 1:  Toxicity scales as defined in: M. A. Kamrin, Pesticide Profiles: Toxicity, 
Environmental Impact, and Fate, Lewis Publishers (Boca Raton, FL, 1997), p. 8 
 
 
By comparison, chemicals such as benzo[a]pyrene have an LC50 of less than 0.1 ppm (Govers et 
al., 1984), and are considered to be very highly toxic. 
 
An interesting observation from the exposure study was that the Daphnia ingested RNIP and 
this NP also coated their carapace (outer shell), including filtering apparatus and appendages 
(Figure 3).  Even though the daphnids were coated with RNIP, they were able to survive and 
were able to feed and reproduce over a 21-day life-cycle test.  The significance of this 
observation is currently not known. 
 
 
 
 
 
 
 
 
 
A B C D
E F
Toxicity Category LC50 (ppm)
Very highly toxic <0.1
Highly toxic 0.1-1.0
Moderately toxic 1.0-10
Slightly toxic 10-100
Practically nontoxic >100  
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Figure 3: Daphnia exposed to various concentrations of RNIP used in remediation. A = control; B 
= 3 mg/L; C = 7.5 mg/L; D = 15 mg/L; E = 30 mg/L; F = 125 mg/L (dead daphnid). All daphnids 
shown are 21 days old and eggs are visible in their brood pouches (small green circles). Note the 
darkening of the digestive tract from A (normal greenish color) to D with increased ingestion of 
RNIP particles (solid arrows). Antennae become clogged with nano-iron in E and F (dashed 
arrows).  
 
 
 
 
 
IV. Fish study 
 
For the fish experiments, we exposed fathead minnows, a standard EPA test species, for 5-days 
to 50 ppm of RNIP.  In the absence of formal standards yet to be established by the EPA for 
using microarray data in exposure studies, we based our fish exposure design on the Daphnia 
range-finding studies and a report in the literature that examined gene expression profiles in 
the sheepshead minnow, which were exposed 4-5 days to a number of different compounds 
that mimic estrogens (Larkin et al., 2003).  The Daphnia range-finding study served as a cost-
effective, quick screen to identify a dose of RNIP that was subsequently used for the fish 
exposures.  Because of the longer exposure time in these studies, we used a slightly lower dose 
of RNIP than the dose used for the Daphnia studies. 
 
Fish were exposed as groups of 3 in 10 liter aquaria (Figure 4), with 5 aquaria serving as 
controls and 5 aquaria containing RNIP (30 fish total). A 50% water change was done at 24 and 
72 hours, and water quality and temperature were monitored and were at all times in normal 
ranges.   
 
 
 
 
 
 
 
 
Figure 4: Control (Left) and 50-ppm RNIP (Right) exposure aquaria, each containing three 
male adult fathead minnows.  Note that the tanks with RNIP had a dark color to the water.   
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Figure 4:  Picture of fathead minnow microarray. 
 
During the 5-day exposure the fish were 
monitored daily for overt physical changes 
(such as lesions).  The concentration used 
did not cause any mortality of the fish.   
Mortality is an endpoint that is currently 
used in acute toxicity tests.  In addition to  
measuring this traditional endpoint, we also 
measured gene expression patterns in the 
fish using a fathead minnow 2000 gene 
microarray that was developed by EcoArray  
 
and the US EPA and implemented on the Agilent® Technologies platform.   The genes on the 
fathead minnow microarray were obtained by sequencing clones obtained from cDNA and 
subtraction libraries that were constructed from different tissues (brain, liver, gonad, gill, and 
others) in male and female fathead minnows.  The 2,000 genes encode proteins that are part of 
a variety of diverse biological pathways in fathead minnows.  Because of the broad 
representation of genes on the microarray, these tools can be used to examine the toxicity of 
nanoparticles.   
 
To carry out the microarray experiments, preserved tissue samples were shipped to EcoArray 
for analysis.  Twenty microarrays were used to examine gene expression patterns in liver and 
gill tissue of fathead minnows exposed to RNIP or vehicle control.     
 
The microarray results revealed that very few genes were robustly changed in the RNIP 
exposed animals compared to controls.  Some genes were differentially regulated based on 
standard statistical measures (t-Tests, P<0.01). These included genes that encode proteins 
involved in tissue repair, inflammation (the first line of defense against any foreign chemical or 
organism), and anti-oxidant defenses.  See Appendix, Table 3 for a summary of some of the 
genes that were changed.   
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V.  Conclusions and Long-Term View 
 
The project demonstrated that a new technology can be brought to bear to the issue of 
screening NP quickly and cost-efficiently.  While there is additional work to be done to develop 
robust databases that can be used to further examine and document the microarray data, 
microarrays show substantial promise of being useful in screening NP products.  Working with a 
new technology in a new area, we came to meaningful conclusions in four months, and at a 
cost that would compare very favorably to current tests.  While these studies measured gene 
expression profiles in fathead minnows exposed to RNIP at a specific dose, additional exposures 
of fathead minnows to RNIP need to be conducted to identify Lowest-observed-effect (LOEL) 
and No observable effect (NOEL) levels.  Furthermore, additional studies that examine other 
endpoints like histology and reproduction could be conducted in the future as well as studies 
that characterize the gene expression profiles in Daphnia that are exposed to RNIP. 
 
The success of the project was also due to Toda Kyogo’s willingness to accommodate the 
project’s needs.   Without knowing what we would find in the aquatic toxicity tests, Biox 
cooperated fully with this study.  This type of openness and readiness to have their product 
tested shows not only a high level of faith in their product, but also their willingness to be 
transparent to the public.   
 
Microarray technology offers several advantages over existing testing methods and may replace 
them when it is fully developed and better understood by the testing community.   The current 
testing approaches are iterative, approximate and expensive.   For example, Donald Versteeg, 
Ph.D., a senior scientist at Procter & Gamble and advisor to EcoArray, estimates the current 
cost of screening a product  for possible endocrine effects are in the $50,000 to $80,000 range 
per compound using draft OECD or US EPA methods.  With advances in combinatorial chemistry 
and molecule design, new compounds are being synthesized rapidly and environmental 
screening costs need to be less than $5,000 per compound to make that new productivity 
worthwhile.  EcoArray estimates that arrays can deliver this kind of cost performance. 
 Environmental remediation assessments would realize similar benefits:  the current cost to test 
a site for toxicants is now $110,000 – 130,000.  A microarray-based approach will cost $30,000 
– 50,000 using 2006 array costs. 
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As has happened in other technologies (e.g. computer chips) the cost of gene microarrays is 
falling over time.    Figure 5 shows a projection of the base cost of microarrays for EcoArray’s 
fathead minnow array.  The chart shows cost per spot, excluding costs to hybridize, scan and 
analyze arrays.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For screening of NP, as well as other compounds, the rapidly falling cost per spot on the 
microarray is important since screens will likely use large microarrays in order to record the 
expression of as many different genes as possible during testing.   
 
The Future 
 
This study can serve as a model to other companies currently developing nanotechnologies.  
Having these types of rapid screening tests (3-4 months) available for companies allows for 
quick screening, data analysis, and data dissemination, and this ultimately will build public trust 
and ensure eco-safe nano-products. 
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Figure 5: Microarray costs. 
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APPENDIX 
 
Table 2:  Some recent funding by the US EPA to develop applications of 
nanoparticles for use in the Environment (US EPA, 2005).   
 
Type of NP 
used 
Potential use Lead PIs and Institutions 
 REMEDIATION  
nanoTiO2 photocatalysis of organic 
contaminants 
DD Dionysiou 
Miami University-Oxford, OH; University of 
Cincinnati, OH 
carbon 
nanostructures 
absorption of organics MB Tomson 
Rice University 
nano-metal 
oxides 
control NOx production S Senkan 
UCLA 
nano-iron degradation of PAH-based 
contaminants 
GV Lowry, SA Majetich, K Matyjaszewski, 
RD Tilton 
Carnegie Mellon University 
nano-
biopolymers 
control of heavy metals W Chen, M Matsumoto, A Mulchandani 
UC Riverside 
bi-metallic nano-
Fe/Pd 
remediation of inorganics and 
organics 
WX Zhang 
Lehigh University 
nano-crystalline 
zeolite 
NOx, photocatalytic oxidation of 
organics 
SC Larsen, VH Grassian 
University of Iowa 
nano-magnetite groundwater contamination M Hull 
Luna Innovations, Inc. 
 FILTRATION  
ferromagnetic 
particles 
using nanocomposites to 
monitor and filter (smart 
particles) 
WM Sigmund, D Mazyck, CY Wu 
University of Florida 
nano-crystalline 
catalysts 
disinfection by-product control 
in drinking water 
SJ Masten and MJ Baumann 
Michigan State University 
nanostructured 
electrodes 
perchlorate from drinking water SM Jaffe 
Material Methods LLC 
 SENSORS  
carbon nano-
particle based 
microchip 
analytical chemistry of 
Environmentally Relevant 
endpoints 
J Wang 
New Mexico State University 
nanocrystalline 
metallic 
conductors 
gas sensor V Subramanian 
UC Berkeley 
colloidal-metal 
nanoparticles 
monitoring Heavy Metals O Sadik, J Wang 
New Mexico State University 
polystyrene detection of aquatic toxins RE Gawley 
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beads coated 
with peptides 
University of Miami 
fullerene tracers for water pollution JB Callegary 
University of Arizona 
 GREEN ENERGY/ 
MANUFACTURING 
 
nano-clay substitute petroleum-based 
products for nano-composites 
LT Drzal, M Misra, AK Mohanty 
Michigan Sate University 
nano-micelles replacing VOCs with nano-
structured microemulsions 
DA Sabatini, JH Harwell 
University of Oklahoma 
nano-plastic 
fibrils and 
crystals 
alternative to Petroleum-based 
composites 
WT Winter 
SUNY College of Environmental Science and 
Forestry 
nano-TiO2 photocatalyst for solar cells G Chumanov 
Clemson University 
semi-conducting 
nanoparticles 
catalyst fuel cells NY Dolney 
University of Michigan-Ann Arbor 
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 Table 3:  Summary of some genes that are differentially regulated (P<0.01) in RNIP 
exposed animals compared to controls.   Many more genes were found to be differentially 
regulated in the liver compared to the gill.   
   
 
 
Gene Hit Definition 
Fold 
Change 
 
Explanation 
UNDER-EXPRESSED IN LIVER – MALES EXPOSED TO NANO-IRON 
Complement 
component C9 
precursor 
-1.3 
Plays a key role in innate and adaptive immunity 
(Boshra et al., 2006) 
 
OVER-EXPRESSED IN LIVER – MALES EXPOSED TO NANO-IRON 
Alpha-2 macroglobulin 
2  
Alpha-2 macroglobulin 
1  
2.0 
1.6 
Act as defense barriers – binding foreign (or 
host) peptides and particles.  (Borth, 1992) 
Selenoprotein Pa 
precursor 
1.8 
An extracelluar glycoprotein; associates with 
endothelial cells; postulated to protect against 
oxidative injury and to transport selenium from 
liver to peripheral tissues.  (Burk et al., 2003) 
Tubulin, alpha-3 1.6  
Involved in microtubulin dynamics (growth and 
shortening of tubules) and possibly motor 
proteins used for intracellular transport.  
Targeted by anticancer drugs.  (Pellegrini and 
Budman, 2005) 
Ubiquitin 1.5 
Plays a role in the process of protein 
degradation.  (Walters et al., 2004) 
Prothrombin precursor 1.5 
Thrombin (which has multiple roles) is 
generated from its inactive precursor 
prothrombin by factor Xa as part of the 
prothrombinase complex.  (Lane et al. epub 
ahead of print.) 
Antithrombin 1.4 
Mediates the activity of heparin, a major 
anticoagulant.  (Munoz and Linhard, 2004) 
Aldolase A fructose-
biphosphate 
1.3 
Plays a role in glucose metabolism (Shiokawa et 
al., 2002) 
Hexokinase 1.2 
Enzyme involved in glycolosis, transcriptional 
regulation and regulation of apoptosis. (Kim and 
Dang, 2005) 
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UNDER-EXPRESSED IN GILL – MALES EXPOSED TO NANOIRON   
Cytosolic alanine 
aminotransferase (c-
AAT) 
-1.2 
Plays a role in  glycolosis and energy production 
(Patel and Olson, 1985)   
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